IP Library › Granted Patent US 7,169,767
Granted Patent B2
US 7,169,767 · App. 10/997,643 · Granted Jan 30, 2007

Ophthalmic compositions containing galactomannan polymers and borate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,169,767
App. No.
10/997,643
Granted
Jan 30, 2007
Kind
B2
Abstract

The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also discloses methods of topical ophthalmic administration of the compositions to the eye.

Claims (8)

1. A method of delivering a pharmaceutical agent to the eye which comprises topically administering to the eye a sterile ophthalmic composition comprising:

a therapeutically effective amount of a pharmaceutically active agent selected from the group consisting of steroidal anti-inflammatory agents, non-steroidal anti-inflammatory agents and combinations thereof;

0.1 to 5% (w/v) of a galactomannan selected from the group consisting of guar, hp guar and combinations thereof;

0.05 to 5% (w/v) of a borate compound; and

water.

2. The method of claim 1 , wherein the galactomannan comprises hp-guar.

3. The method of claim 1 , wherein the pharmaceutically active agent comprises a steroidal anti-inflammatory agent.

4. The method of claim 1 , wherein the pharmaceutically active agent comprises a non-steroidal anti-inflammatory agent.